Intravital imaging of three different microvascular beds in SARS-CoV-2-infected mice.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
08 08 2023
Historique:
accepted: 29 05 2023
received: 28 11 2022
medline: 2 8 2023
pubmed: 12 6 2023
entrez: 12 6 2023
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) enters the respiratory tract, where it infects the alveoli epithelial lining. However, patients have sequelae that extend well beyond the alveoli into the pulmonary vasculature and, perhaps, beyond to the brain and other organs. Because of the dynamic events within blood vessels, histology does not report platelet and neutrophil behavior. Because of the rapid nontranscriptional response of these cells, neither single-cell RNA sequencing nor proteomics report robustly on their critical behaviors. We used intravital microscopy in level-3 containment to examine the pathogenesis of SARS-CoV-2 within 3 organs in mice expressing human angiotensin converting enzyme 2 (ACE-2) ubiquitously (CAG-AC-70) or on epithelium (K18-promoter). Using a neon-green SARS-CoV-2, we observed both the epithelium and endothelium infected in AC70 mice but only the epithelium in K18 mice. There were increased neutrophils in the microcirculation but not in the alveoli of the lungs of AC70 mice. Platelets formed large aggregates in the pulmonary capillaries. Despite only neurons being infected within the brain, profound neutrophil adhesion forming the nidus of large platelet aggregates were observed in the cerebral microcirculation, with many nonperfused microvessels. Neutrophils breached the brain endothelial layer associated with a significant disruption of the blood-brain-barrier. Despite ubiquitous ACE-2 expression, CAG-AC-70 mice had very small increases in blood cytokine, no increase in thrombin, no infected circulating cells, and no liver involvement suggesting limited systemic effects. In summary, our imaging of SARS-CoV-2-infected mice gave direct evidence that there is a significant perturbation locally in the lung and brain microcirculation induced by local viral infection leading to increased local inflammation and thrombosis in these organs.

Identifiants

pubmed: 37307197
pii: 496268
doi: 10.1182/bloodadvances.2022009430
pmc: PMC10284260
doi:

Substances chimiques

K-18 conjugate 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4170-4181

Subventions

Organisme : CIHR
ID : 177704
Pays : Canada
Organisme : CIHR
ID : 175622
Pays : Canada
Organisme : CIHR
ID : MFE-176551
Pays : Canada

Informations de copyright

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
EBioMedicine. 2021 Jan;63:103182
pubmed: 33422990
Blood. 1995 Oct 1;86(7):2760-6
pubmed: 7545469
Front Cell Infect Microbiol. 2021 Jul 06;11:701278
pubmed: 34307198
J Virol. 2015 Feb;89(3):1537-49
pubmed: 25428869
Cell Rep. 2021 May 4;35(5):109055
pubmed: 33905739
J Clin Invest. 2017 Jun 1;127(6):2249-2261
pubmed: 28463232
Cell. 2020 Oct 1;183(1):110-125.e11
pubmed: 32888431
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
J Immunol. 2009 Oct 15;183(8):5244-50
pubmed: 19786543
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nat Immunol. 2013 Aug;14(8):785-92
pubmed: 23770641
Sci Immunol. 2017 Apr 28;2(10):
pubmed: 28626833
J Exp Med. 2000 Oct 16;192(8):1205-11
pubmed: 11034611
Sci Rep. 2022 Mar 8;12(1):3794
pubmed: 35260703
Am J Physiol. 1996 May;270(5 Pt 1):L836-45
pubmed: 8967519
mBio. 2020 Dec 11;11(6):
pubmed: 33310781
Nat Rev Immunol. 2021 May;21(5):319-329
pubmed: 33824483
J Hepatol. 2020 Aug;73(2):451-453
pubmed: 32278005
Nat Med. 2011 Nov 07;17(11):1381-90
pubmed: 22064428
Nat Rev Immunol. 2013 Jan;13(1):34-45
pubmed: 23222502
Blood. 2017 Mar 9;129(10):1357-1367
pubmed: 28073784
J Immunol. 2002 Jul 15;169(2):1000-6
pubmed: 12097407
EBioMedicine. 2021 Aug;70:103500
pubmed: 34311326
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33433624
Clin Transl Immunology. 2021 Oct 24;10(10):e1350
pubmed: 34721846
Nature. 2022 Apr;604(7907):697-707
pubmed: 35255491
J Clin Med. 2020 May 11;9(5):
pubmed: 32403217
JCI Insight. 2018 May 3;3(9):
pubmed: 29720578
Cell Host Microbe. 2020 May 13;27(5):841-848.e3
pubmed: 32289263
Immunol Rev. 2023 Mar;314(1):399-412
pubmed: 36440642
Nat Cell Biol. 2009 Mar;11(3):328-36
pubmed: 19198598
Nat Med. 2007 Apr;13(4):463-9
pubmed: 17384648
Neuroscientist. 2021 Dec;27(6):582-603
pubmed: 32914699
Cells. 2021 Jul 27;10(8):
pubmed: 34440669
Circulation. 2021 Feb 23;143(8):865-868
pubmed: 33405941
Nat Rev Immunol. 2007 Sep;7(9):678-89
pubmed: 17717539
Cell Death Dis. 2020 Dec 8;11(12):1042
pubmed: 33293527
Immunol Rev. 2019 May;289(1):9-30
pubmed: 30977202
Am J Physiol Lung Cell Mol Physiol. 2000 Dec;279(6):L1083-90
pubmed: 11076798
Immunity. 2021 Sep 14;54(9):2143-2158.e15
pubmed: 34453881
Nat Cell Biol. 2008 Feb;10(2):211-9
pubmed: 18193035
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H473-81
pubmed: 16443672
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Platelets. 2015;26(4):286-92
pubmed: 25806786
Cell. 2020 May 14;181(4):905-913.e7
pubmed: 32333836
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093

Auteurs

Fernanda V S Castanheira (FVS)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Rita Nguyen (R)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Michelle Willson (M)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Marcela Davoli-Ferreira (M)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Bruna A David (BA)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Margaret M Kelly (MM)

Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.
Pathology and Laboratory Medicine, University of Calgary, Calgary, AB.
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB.

Woo-Yong Lee (WY)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Rachel M Kratofil (RM)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Wen X Zhang (WX)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Maxwell Bui-Marinos (M)

Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.
Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB.

Jennifer A Corcoran (JA)

Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.
Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB.

Paul Kubes (P)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB.
Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB.
Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH